IGM Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
IGM Biosciences, Inc. had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $19.36 million as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2025-03-06
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $19.36M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $22.30M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $28.60M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $17.50M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2024-12-31 | $19.36M 10-K · filed 2025-03-06 |
| 2023-12-31 | $22.30M 10-K · filed 2024-03-07 |
| 2022-12-31 | $28.60M 10-K · filed 2023-03-30 |
| 2021-12-31 | $17.50M 10-K · filed 2022-03-29 |
| 2020-03-31 | $733.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $733.00K 10-K · filed 2020-03-26 |